4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide

Catalog No. :
ACESXJ640
CAS No. :
526-08-9
Molecular Formula :
C15H14N4O2S
Molecular Weight :
314.37

IUPAC Name:4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide

4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg99%$75.00Login to see priceIn stockIn stock
1g99%$186.00Login to see priceIn stockIn stock
5g99%$651.00Login to see priceIn stockInquiry
25g99%$2576.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide
IUPAC Name4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide
MDL No.MFCD00057226
Molecular FormulaC15H14N4O2S
Molecular Weight314.37
SMILESO=S(C1=CC=C(N)C=C1)(NC2=CC=NN2C3=CC=CC=C3)=O
InChI KeyQWCJHSGMANYXCW-UHFFFAOYSA-N
Synonym1420043-53-3 | SULFAPHENAZOLE [MART.] | DivK1c_000303 | NSC-757859 | Prestwick0_000021 | Spectrum_001406 | MLS001056713 | Sulfafenazol (INN-Spanish) | HMS2095E03 | N'-(1-Phenylpyrazol-5-yl)sulfanilamide | Paidazolo | Prestwick_454 | Sulfaphenylpyrazol | 0
CAS No.526-08-9
PubChem CID5335

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACESXJ640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACESXJ640 route product structure diagram
    ACESXJ640526-08-9 In Stock
Inquiry

2. ACESXJ640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLXKB268 route compound structure diagram
    ACLXKB268826-85-7 In Stock
  4. Then
  5. ACESXJ640 route product structure diagram
    ACESXJ640526-08-9 In Stock
Inquiry

Comments (0)